586 related articles for article (PubMed ID: 22318619)
1. The innovative medicines initiative: a European response to the innovation challenge.
Goldman M
Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
[TBL] [Abstract][Full Text] [Related]
2. [The Innovative Medicine Initiative (IMI)].
Bril A; Canet E
Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
[TBL] [Abstract][Full Text] [Related]
3. The innovative medicines initiative: a public private partnership model to foster drug discovery.
Vaudano E
Comput Struct Biotechnol J; 2013; 6():e201303017. PubMed ID: 24688725
[TBL] [Abstract][Full Text] [Related]
4. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
Laverty H; Gunn M; Goldman M
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
[No Abstract] [Full Text] [Related]
5. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
Ioset JR; Chang S
Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
[TBL] [Abstract][Full Text] [Related]
6. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
8. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
[TBL] [Abstract][Full Text] [Related]
9. Universities shun Europe's drug initiative.
Gilbert N
Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
[No Abstract] [Full Text] [Related]
10. The Innovative Medicines Initiative moves translational immunology forward.
Goldman M; Wittelsberger A; De Magistris MT
Eur J Immunol; 2013 Feb; 43(2):298-302. PubMed ID: 23534061
[TBL] [Abstract][Full Text] [Related]
11. Open PHACTS: semantic interoperability for drug discovery.
Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
[TBL] [Abstract][Full Text] [Related]
12. Leveraging public private partnerships to innovate under challenging budget times.
Portilla LM; Rohrbaugh ML
Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
[TBL] [Abstract][Full Text] [Related]
13. An audience with...Francis Collins. Interviewed by Asher Mullard.
Collins F
Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
[No Abstract] [Full Text] [Related]
14. Reflections on the Innovative Medicines Initiative.
Goldman M
Nat Rev Drug Discov; 2011 May; 10(5):321-2. PubMed ID: 21532547
[TBL] [Abstract][Full Text] [Related]
15. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
Zhang Z; Jia M; Wan D
Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
[TBL] [Abstract][Full Text] [Related]
16. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
17. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
[TBL] [Abstract][Full Text] [Related]
18. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
19. Crowdsourcing in pharma: a strategic framework.
Bentzien J; Bharadwaj R; Thompson DC
Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
